Australia faces a perplexing paradox: despite its status as a developed country with significant advances in medical technology, it continues to suffer from persistent medication shortages. These shortages are largely due to the nation's heavy dependence on imported pharmaceuticals and the
Ecolab Life Sciences has unveiled a state-of-the-art bioprocessing applications laboratory in King of Prussia, Pennsylvania, setting the stage for significant advances in pharmaceutical innovation. This laboratory is specifically designed to offer technical support and process development services
Ecolab Life Sciences has introduced a groundbreaking Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania, setting new standards in supporting biopharmaceutical firms with molecule purification. Nestled strategically near key pharmaceutical hubs, these facilities are designed to
The Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) stands as a formidable force reshaping the U.S. biomanufacturing sector amid the demand for sustainable and efficient biotechnological solutions. Since its inception in 2009 under the U.S. Department of Energy's Bioenergy
When it comes to the rapidly evolving field of cell and gene therapy (CGT), Ivan Kairatov stands out as a seasoned expert with significant insight into technological advances and strategic partnerships. His expertise is pivotal in understanding Matica Bio’s collaboration with Texas A&M’s Nat
The European Union is experiencing a notable shift within its medical device sector due to evolving regulatory frameworks, sparked by developments expected by early 2025. Beginning with a focus on key regulatory updates and industry responses, this transformation is deeply rooted in the frameworks
